Dr. Victor Engelhard serves as Director of the Beirne B. Carter Center for Immunology Research. Dr. Engelhard received his B.S. in Biochemistry from Rice University and his M.S. and Ph.D. in Biochemistry from the University of Illinois. During his postdoctoral fellowship at Harvard University with Jack Strominger, he studied the molecular requirements for antigen recognition by T lymphocytes. He is currently Professor of Microbiology, Immunology and Cancer Biology, and Beirne B. Carter Professor in Immunology. He is also Co-Leader of the Immunology and Immunotherapy Program of the University of Virginia Cancer Center, and Co-Director of the Human Immune Therapy Center.
Dr. Engelhard has trained over 50 graduate students, postdoctoral fellows, and visiting scientists. He was awarded the Robert J Kadner Distinguished Teaching Award in 2008, and the David A. Harrison Distinguished Educator Award in 2006. He is currently Director of the Immunology Training Program and PI of its NIH-sponsored Training Grant.
Engelhard served on the Experimental Immunology Study Section (1986-90), the Tumors Transplantation and Tolerance Study Section (2005-08), the NIAID Expert Panel on Transplantation Tolerance (1995), and the NIAID Epitope Discovery Working Group (2006-09). He has been a Section Editor for the Journal of Immunology, Advisory Editor of the Journal of Experimental Medicine, Associate Editor of Immunity, and a member of the Faculty of 1000 Immunology Section.
The work of Dr. Engelhard’s laboratory over the last 36 years has been broadly concerned with the recognition of antigens by CD8 T lymphocytes. In the last 25 years, that work has focused on tumor-derived antigens and cancer immunology. His research activities have led to 190 peer-reviewed and invited publications. Current activities in the laboratory are almost exclusively concerned with immune responses to tumors and ways to enhance the immune response for control of cancer.